1. Home
  2. LEXX vs EHGO Comparison

LEXX vs EHGO Comparison

Compare LEXX & EHGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • EHGO
  • Stock Information
  • Founded
  • LEXX 2004
  • EHGO 2015
  • Country
  • LEXX Canada
  • EHGO China
  • Employees
  • LEXX N/A
  • EHGO N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • EHGO
  • Sector
  • LEXX Health Care
  • EHGO
  • Exchange
  • LEXX Nasdaq
  • EHGO NYSE
  • Market Cap
  • LEXX 38.9M
  • EHGO 91.9M
  • IPO Year
  • LEXX N/A
  • EHGO 2024
  • Fundamental
  • Price
  • LEXX $2.23
  • EHGO $3.33
  • Analyst Decision
  • LEXX Strong Buy
  • EHGO
  • Analyst Count
  • LEXX 2
  • EHGO 0
  • Target Price
  • LEXX $11.00
  • EHGO N/A
  • AVG Volume (30 Days)
  • LEXX 202.7K
  • EHGO 580.9K
  • Earning Date
  • LEXX 01-10-2025
  • EHGO 02-15-2025
  • Dividend Yield
  • LEXX N/A
  • EHGO N/A
  • EPS Growth
  • LEXX N/A
  • EHGO N/A
  • EPS
  • LEXX N/A
  • EHGO 0.00
  • Revenue
  • LEXX $464,278.00
  • EHGO $16,963,957.00
  • Revenue This Year
  • LEXX $20.39
  • EHGO N/A
  • Revenue Next Year
  • LEXX $113.25
  • EHGO N/A
  • P/E Ratio
  • LEXX N/A
  • EHGO $8,954.67
  • Revenue Growth
  • LEXX 105.24
  • EHGO N/A
  • 52 Week Low
  • LEXX $1.20
  • EHGO $1.45
  • 52 Week High
  • LEXX $6.85
  • EHGO $5.50
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 47.23
  • EHGO N/A
  • Support Level
  • LEXX $2.00
  • EHGO N/A
  • Resistance Level
  • LEXX $2.54
  • EHGO N/A
  • Average True Range (ATR)
  • LEXX 0.24
  • EHGO 0.00
  • MACD
  • LEXX -0.00
  • EHGO 0.00
  • Stochastic Oscillator
  • LEXX 27.06
  • EHGO 0.00

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

About EHGO ESHALLGO INC

Eshallgo Inc. focuses on two distinct market sectors: office supply sale and leasing, and after-sale maintenance and repair. It is an authorized distributor of brands of office equipment, including HP, Epson, Xerox, Sharp, Toshiba, Konica, Kyocera, and other brands.

Share on Social Networks: